Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 7/20 | 0.53 |
| ▸ | TSHR | P16473 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 9/20 | 0.50 |
| ▸ | HPGD | P15428 | 7/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.50 |
| ▸ | GAA | P10253 | 3/20 | 0.50 |
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | CA9 | Q16790 | 2/20 | 0.50 |
| ▸ | MPO | P05164 | 1/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.50 |
| ▸ | CA2 | P00918 | 1/20 | 0.50 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.50 |
| ▸ | CA4 | P22748 | 1/20 | 0.50 |
| ▸ | CA6 | P23280 | 1/20 | 0.50 |
| ▸ | CA7 | P43166 | 1/20 | 0.50 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.50 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9797513 | 0.79 | KDM4E (0.67) | LMNATSHRKDM4EHPGDALDH1A1 | |
| SCHEMBL29861559 | 0.79 | KDM4E (0.67) | LMNATSHRKDM4EHPGDALDH1A1 | |
| SCHEMBL1191330 | 0.79 | HPGD (0.48) | KDM4EHPGDSMN1; SMN2GAAHTT | |
| SCHEMBL9826699 | 0.79 | LMNA (0.48) | LMNATSHRKDM4EHPGDALDH1A1 | |
| Methane SCHEMBL27563431 | 0.79 | KDM4E (0.50) | LMNATSHRKDM4EHPGDALDH1A1 | |
| SCHEMBL1799299 | 0.78 | KDM4E (0.65) | LMNATSHRKDM4EHPGDALDH1A1 | |
| SCHEMBL7531392 | 0.78 | GAA (0.66) | LMNAHPGDALDH1A1SMN1; SMN2GAA | |
| SCHEMBL16385647 | 0.78 | ALDH1A1 (0.55) | KDM4EHPGDALDH1A1GAAHSD17B10 | |
| SCHEMBL2154229 | 0.77 | LMNA (0.47) | LMNATSHRKDM4EHPGDALDH1A1 | |
| SCHEMBL6626324 | 0.77 | LMNA (0.47) | LMNATSHRKDM4EHPGDALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6831197-B2 | Intermediates, in particular for preparing fungicides | BAYER AKTIENGESELLSCHAFT (DE) | 2004-12-14 | — | — | US | disclosed |
| US-20040147782-A1 | Methods for producing 2-(2-hydroxyphenyl)-2-(alkoxyimino)-N-methylacetamide derivatives | HUBSCH WALTER (DE) | 2004-07-29 | — | — | US | disclosed |
| US-6700017-B1 | ALKYLATION, OXIDATION | BAYER AKTIENGESELLSCHAFT (DE) | 2004-03-02 | — | — | US | disclosed |
| CN-1399628-A | Methods for producing 2-(2-hydroxyphenyl)-2-(alkoxyimino)-n-methylacetamide derivatives | BAYER AG (DE) | 2003-02-26 | — | — | CN | disclosed |
| EP-1235790-A2 | METHODS FOR PRODUCING 2-(2-HYDROXYPHENYL)-2-(ALKOXYIMINO)-N-METHYLACETAMIDE DERIVATIVES | Bayer Aktiengesellschaft (DE) | 2002-09-04 | — | — | EP | disclosed |
| WO-2001038294-A2 | METHODS FOR PRODUCING 2-(2-HYDROXYPHENYL)-2-(ALKOXYIMINO)-N-METHYLACETAMIDE DERIVATIVES | BAYER AKTIENGESELLSCHAFT (DE) | 2001-05-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040147782-A1 | Methods for producing 2-(2-hydroxyphenyl)-2-(alkoxyimino)-N-methylacetamide derivatives | AADAC, HACL2, AZI2 | LMNA 1724/4885TSHR 4354/4885KDM4E 3677/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.